Clinical trial
Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for…
NCT00432341 · Allergan, Industry · Terminated
Key facts
| NCT number | NCT00432341 |
|---|---|
| Title | Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia |
| Lead sponsor | Allergan, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Spasmodic Torticollis |
| Intervention type | Biological |
| Interventions | botulinum toxin type A |
| Enrollment | 54 |
| Start date | Jun 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Feb 7, 2007 |
| Last update posted | Dec 16, 2011 |
| Countries | Argentina, Australia, India |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: